These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10684841)

  • 1. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
    Kanno M; Araie M; Koibuchi H; Masuda K
    Br J Ophthalmol; 2000 Mar; 84(3):293-9. PubMed ID: 10684841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-intensity focused ultrasound (HiFU) treatment on intraocular pressure and aqueous humour dynamics: 12 -months results.
    Nagar A; Daas A; Danieliute L; Alaghband P; Yu-Wai-Man C; Amon A; Galvis E; Lim KS
    Eye (Lond); 2021 Sep; 35(9):2499-2505. PubMed ID: 33159175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct measurement of pressure-independent aqueous humour flow using iPerfusion.
    Madekurozwa M; Reina-Torres E; Overby DR; Sherwood JM
    Exp Eye Res; 2017 Sep; 162():129-138. PubMed ID: 28720436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allometry and Scaling of the Intraocular Pressure and Aqueous Humour Flow Rate in Vertebrate Eyes.
    Zouache MA; Eames I; Samsudin A
    PLoS One; 2016; 11(3):e0151490. PubMed ID: 26990431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography.
    Kim S; Chen V; Pottenburgh J; Cruz M; Cooper G; Sun C; Im L; Magder L; Saeedi OJ
    Ophthalmol Sci; 2024; 4(5):100533. PubMed ID: 39071915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit.
    Anderson SG; Meyer D; Decloedt EH
    J Ocul Pharmacol Ther; 2024 May; ():. PubMed ID: 38800944
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitric oxide: an old drug but with new horizons in ophthalmology-a narrative review.
    Lee S; Park CY
    Ann Transl Med; 2023 Aug; 11(10):352. PubMed ID: 37675299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure Clamping During Ocular Perfusions Drives Nitric Oxide-Mediated Washout.
    Kelly RA; McDonnell FS; De Ieso ML; Overby DR; Stamer WD
    Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):36. PubMed ID: 37358489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Application of Nitric Oxide for Ocular Hypertension Treatment.
    Han B; Song M; Li L; Sun X; Lei Y
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Alpha1-Adrenoceptor Antagonists and Increased Risk of Open-Angle Glaucoma: A Nationwide Population-Based Cohort Study.
    Lin HZ; Hsieh TC; Wu JL; He MS; Lee YC
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):15. PubMed ID: 32766746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.
    Mayama C; Araie M
    Jpn J Ophthalmol; 2013 Mar; 57(2):133-49. PubMed ID: 23321913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrobulbar hemodynamic effects of nipradilol in normal and normal-tension glaucoma eyes.
    Fukukita M; Ido M; Osawa S; Sasoh M; Furuta M; Ito K; Sugimoto M; Uji Y
    J Ophthalmol; 2011; 2011():652904. PubMed ID: 22132312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma.
    Inoue K; Noguchi K; Wakakura M; Tomita G
    Clin Ophthalmol; 2011; 5():1211-6. PubMed ID: 21966188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.
    Araie M; Shirato S; Yamazaki Y; Kitazawa Y; Ohashi Y;
    Jpn J Ophthalmol; 2010 Jul; 54(4):278-85. PubMed ID: 20700793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiglaucoma drugs for achieving monovision after laser in situ keratomileusis.
    Kamiya K; Shimizu K
    Clin Ophthalmol; 2009; 3():211-3. PubMed ID: 19668567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma?
    Moore D; Harris A; Wudunn D; Kheradiya N; Siesky B
    Clin Ophthalmol; 2008 Dec; 2(4):849-61. PubMed ID: 19668439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The additive effects on intraocular pressure of combining nipradilol 0.25% and latanoprost 0.005% ophthalmic solutions: a prospective, randomized, multicenter study.
    Tsuru T; Kitazawa Y; Usui M; Ueno S; Azuma I; Masuda K
    Jpn J Ophthalmol; 2008; 52(5):368-373. PubMed ID: 18991037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: a multicenter, randomized, double-masked comparative study.
    Araie M; Shirato S; Yamazaki Y; Kitazawa Y; Ohashi Y;
    Jpn J Ophthalmol; 2008; 52(4):255-264. PubMed ID: 18773262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-adrenergic receptor antagonists on oxidative stress in purified rat retinal ganglion cells.
    Yu ZK; Chen YN; Aihara M; Mao W; Uchida S; Araie M
    Mol Vis; 2007 Jun; 13():833-9. PubMed ID: 17615544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma.
    Haneda M; Shirato S; Maruyama K; Ohno Y
    Jpn J Ophthalmol; 2006; 50(1):33-7. PubMed ID: 16453185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.